Egg on my face: yesterday, I suggested that an ICER white paper, prepared for CMS as a part of the price-setting process for Eliquis and Xarelto, showed that those two
This journal article makes the case -- via analysis of claims data -- that patients almost never fill scripts for obesity medicines. The topline is that 10 of every 11
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv